News Search

Clinical trial shows that solanezumab, an antibody-based treatment for Alzheimer’s disease, does not significantly slow cognitive decline.

A mutation that leads to relapse in many leukemia patients also causes a weakness that could be exploited to kill the cancer cells, Columbia researchers have reported.

The internal anatomy of our lungs is surprisingly variable, and some variations are associated with a greater risk of chronic obstructive pulmonary disease, CUIMC researchers have found.